Gene therapy in the CNS
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (2), 93-109
- https://doi.org/10.1038/sj.gt.3301119
Abstract
Gene therapy for neurological disorder is currently an experimental concept. The goals for clinical utilization are the relief of symptoms, slowing of disease progression, and correction of genetic abnormalities. Experimental studies are realizing these goals in the development of gene therapies in animal models. Discoveries of the molecular basis of neurological disease and advances in gene transfer systems have allowed focal and global delivery of therapeutic genes for a wide variety of CNS disorders. Limitations are still apparent, such as stability and regulation of transgene expression, and safety of both vector and expressed transgene. In addition, the brain adds several challenges not seen in peripheral gene therapy paradigms, such as post-mitotic cells, heterogeneity of cell types and circuits, and limited access. Moreover, it is likely that several modes of gene delivery will be necessary for successful gene therapies of the CNS. Collaborative efforts between clinicians and basic researchers will likely yield effective gene therapy in the CNS.Keywords
This publication has 99 references indexed in Scilit:
- Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsyAnnals of Neurology, 1998
- Immortalized neural progenitor cells for CNS gene transfer and repairTrends in Neurosciences, 1997
- Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: Trophic and tropic effects in a rodent model of Huntington's diseaseJournal of Comparative Neurology, 1997
- Practical Aspects of the Development ofex Vivoandin VivoGene Therapy for Parkinson's DiseaseExperimental Neurology, 1997
- Gene Therapeutic Strategies for Neuroprotection: Implications for Parkinson's DiseaseExperimental Neurology, 1997
- Generation of DOPA-Producing Astrocytes by Retroviral Transduction of the Human Tyrosine Hydroxylase Gene:In VitroCharacterization andin VivoEffects in the Rat Parkinson ModelExperimental Neurology, 1996
- Targeting Epilepsy GenesNeuron, 1996
- Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosisNature Genetics, 1994
- Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopaNeuron, 1991
- A latent, nonpathogenic HSV-1-derived vector stably expresses β-galactosidase in mouse neuronsNeuron, 1990